[July 26, 2016]

Autoimmune Haemolytic Anemia Forecast in 8 Major Markets 2016-2026 - Research and Markets

Research and Markets has announced the addition of the "Autoimmune Haemolytic Anemia Forecast in 8 Major Markets 2016-2026" report to their offering.

Autoimmune haemolytic anaemia (AIHA) is an immune disorder caused by auto-antibodies against unmodified autologous red blood cells and can range in presentation from a mild illness to a rapidly fatal severe condition.

This report provides the current incident population for AIHA across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Reasons to Buy:

• Able to quantify patient populations in global AIHA's market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the incidence of the subdivided types of AIHA and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Provide a level of understanding on the impact from specific co-morbid conditions on AIHA's incident population.
• Identify sub-populations within AIHA which require treatment.
• Gain an understanding of the specific markets that have the largest number of AIHA patients.
  
  
  
  

Key Topics Covered:

1. List of Tables and Figures

2. Introduction

3. Cause of the Disease

4. Risk Factors & Prevention

5. Diagnosis of the Disease

6. Variation by Geography/Ethnicity

7. Disease Prognosis (News - Alert) & Clinical Course

8. Clinical Management of AIHA

9. Key Co-morbid Conditions/Features Associated with the Disease

10. Methodology for Quantification of Patient Numbers

11. Top-Line Incidence for AIHA

12 Sub-types of AIHA patients

13. Market Forecast for AIHA

14. Methodology for Forecast Figures

15. Abbreviations used in the report

16. Patient-Based Offering

17. Online Pricing Data and Platforms

18. References

19. Appendix

For more information visit http://www.researchandmarkets.com/research/r84q5w/autoimmune

View source version on businesswire.com: http://www.businesswire.com/news/home/20160726005767/en/

[ Back To TMCnet.com's Homepage ]